One fatal Nipah case in Bangladesh, and a seasonal exposure route that keeps repeating

On 3 February the International Health Regulations National Focal Point for Bangladesh notified the World Health Organization of one laboratory-confirmed Nipah virus infection in Rajshahi Division, in the country's northwest [s1]. The patient died the day she was admitted to hospital [s1].

One case is not an outbreak. Nipah is a pathogen where the reporting threshold is one case, and the reason lies in the case fatality ratio: across previous outbreaks in Bangladesh, India, Malaysia, the Philippines and Singapore, it has ranged from 40% to 75%, depending on local capacity for early detection and clinical management [s1].

The sequence

The patient is a woman aged between 40 and 50, resident in Naogaon District [s1]. She developed symptoms on 21 January — fever, headache, muscle cramps, loss of appetite, weakness and vomiting — followed by hypersalivation, disorientation and convulsion [s1].

On 27 January she became unconscious and was referred by a local physician to a tertiary hospital [s1]. She was admitted on 28 January; the Nipah surveillance team collected throat swabs and blood samples, and she died the same day [s1]. Infection was confirmed by PCR and ELISA on 29 January [s1].

She reported no travel history, and repeated consumption of raw date palm sap between 5 and 20 January 2026 [s1].

Why raw sap keeps appearing in these reports

Fruit bats of the genus Pteropus — flying foxes — are the natural hosts of Nipah virus, and infection does not appear to cause disease in them [s1][s2]. Transmission to humans can occur through direct contact with infected animals, or by consuming fruits or fruit products such as raw date palm juice contaminated by infected bats [s2].

Date palm sap is collected overnight from cuts made in the trunk, and bats feed at the collection points. That is the mechanism behind the seasonality WHO describes: Bangladesh has small Nipah outbreaks at different times of year, but they tend to occur between December and April, corresponding with the harvesting and consumption of date palm sap [s1].

Bangladesh reported its first Nipah case in 2001, and human infections have been reported almost every year since [s1]. In 2025, four laboratory-confirmed fatal cases were reported from Bangladesh [s1].

The contact picture

Thirty-five contacts have been identified: three household contacts, 14 community contacts and 18 hospital contacts [s1]. Samples were collected from the six who were symptomatic — three household, two community, one hospital — and all six tested negative for Nipah by PCR and for anti-Nipah IgM by ELISA [s1]. As of 3 February no additional cases had been identified, and contacts remain under monitoring [s1].

The hospital figure is the one to hold in mind. Nipah spreads person to person, and health-care settings are where that has repeatedly happened, along with transmission among family and caregivers through close contact [s2]. WHO notes the risk of spread increases in overcrowded, poorly ventilated hospital environments with inadequate infection prevention and control [s2].

Six negative tests among symptomatic contacts is reassuring but not conclusive. The incubation period ranges from 3 to 14 days, and in rare cases incubation of up to 45 days has been reported [s1][s2]. Monitoring windows are set accordingly.

The response

On 30 January the Ministry of Health and Family Welfare, working with other sectors, began an outbreak investigation using a coordinated One Health approach [s1]. Active contact tracing was implemented [s1].

WHO lists further measures as under preparation rather than complete: an advocacy meeting involving Civil Surgeons, Upazila Health Officers, hospital directors and superintendents from Nipah-endemic districts; community awareness programmes involving field-level health workers; and audio-visual health education materials for point-of-entry staff and travellers [s1].

WHO assesses the overall public health risk from this event as low at national, regional and global level, and the risk of international spread as low [s1].

What there is to treat with

Nothing specific. There are currently no licensed medicines or vaccines for Nipah virus infection, and early intensive supportive care is the recommended approach to severe respiratory and neurological complications [s1]. Several candidate products are in development [s2].

Nipah is designated a priority pathogen for the acceleration of medical countermeasures under the WHO R&D Blueprint for Epidemics [s1] — a designation that describes the gap rather than closing it.

Among people who survive, most make a full recovery, but long-term neurological conditions have been reported in approximately one in five [s2].

What to watch

Whether any of the 35 contacts converts over the coming weeks, particularly the hospital contacts, whose exposure occurred during the patient's final, most infectious days.

Whether further sap-linked cases appear in Rajshahi Division before the harvesting season ends in April.

And whether the awareness and point-of-entry materials WHO describes as being developed are in place before the next season rather than during it. The exposure route here is known, seasonal and predictable, which makes the timing of prevention messaging the variable that matters.

Sources

• [s1] World Health Organization, "Disease Outbreak News: Nipah virus infection – Bangladesh," 6 February 2026. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON594
• [s2] World Health Organization, "Nipah virus" fact sheet, accessed 9 February 2026. https://www.who.int/news-room/fact-sheets/detail/nipah-virus